512 HEMOPHILUS INFLUENZAE TYPE B(HIB) POLYSACCHARIDE VACCINE: SAFETY AND IMMUNOGENICITY OF PRP AND PRP-D CONJUGATE VACCINES IN CHILDREN 16–24 MONTHS
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.